Repligen Corp. buy UBS Group AG
Start price
03.11.23
/
50%
€140.20
Target price
03.11.24
€158.58
Performance (%)
-10.02%
End price
04.11.24
€126.15
Summary
This prediction ended on 04.11.24 with a price of €126.15. The price of Repligen Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.02%. UBS_Group_AG has a follow-up prediction for Repligen Corp. where he still thinks Repligen Corp. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Repligen Corp. | -4.158% | -4.158% | -17.235% |
| iShares Core DAX® | 0,19 % | -1,22 % | 8,84 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % | -1,14 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % | 27,58 % |
| iShares S&P 500 | -1,01 % | -3,40 % | -0,22 % |
Comments by UBS_Group_AG for this prediction
In the thread Repligen Corp. diskutieren
Repligen Co. (NASDAQ: RGEN) had its price target lowered by analysts at UBS Group AG from $210.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for RGEN provided by MarketBeat
In the thread Trading Repligen Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Repligen Corp.
Stopped prediction by UBS_Group_AG for Repligen Corp.
Repligen Corp.
Start price
Target price
Perf. (%)
€154.80
31.07.24
31.07.24
€171.14
31.07.25
31.07.25
-34.59%
01.08.25
01.08.25
